Literature DB >> 34362341

Efficacy of gelatin sponge impregnated with ropivacaine on postoperative pain after transforaminal lumbar interbody fusion: a comparative study.

Shanxi Wang1, Bo Wang1, Xiaojun Yu1, Tian Ma1, Mubotu C Ntambale1, Jiyuan Yan1, Qing Ding1, Ruizhuo Zhang1, Hua Wu2, Chaoxu Liu3.   

Abstract

BACKGROUND: The purpose of this study was to investigate the efficacy of gelatin sponge impregnated with ropivacaine on postoperative pain after transforaminal lumbar interbody fusion (TLIF) in patients with lumbar degenerative diseases.
METHODS: We retrospectively reviewed patients who underwent TLIF in our department between August 2018 and January 2020. Patients were divided to ropivacaine group and saline group. A ropivacaine group whom received gelatin sponge impregnated with ropivacaine during operation, and a saline group whom were intraoperatively administered by gelatin sponge impregnated with saline. The two groups were compared in reference to postoperative hospital stay, postoperative complications and visual analog scale (VAS) scores. The consumption of postoperative diclofenac sodium suppository use was also recorded. The Oswestry Disability Index (ODI) scores and Japanese Orthopedic Association (JOA) scores were used for functional evaluation at 1 year postoperatively. RESULT: A total of 127 patients were evaluated in this retrospective study. The mean postoperative hospital stay in the ropivacaine group was significantly lower than saline group. The VAS score was significantly lower in patients receiving gelatin sponge impregnated with ropivacaine as compared with patients in saline group on postoperative day 1, 2, 3 and 4. The number of patients who need the administration of diclofenac sodium suppository and the mean consumption of postoperative diclofenac sodium suppository was significantly lower in the ropivacaine group as compared with saline group.
CONCLUSION: The application of gelatin sponge impregnated with ropivacaine around the nerve root in patients undergoing TLIF can effectively control the postoperative pain and reduce postoperative hospital stay.
© 2021. The Author(s).

Entities:  

Keywords:  Gelatin sponge; Lumbar degenerative diseases; Postoperative pain; Ropivacaine; Transforaminal lumbar interbody fusion

Year:  2021        PMID: 34362341     DOI: 10.1186/s12891-021-04541-w

Source DB:  PubMed          Journal:  BMC Musculoskelet Disord        ISSN: 1471-2474            Impact factor:   2.362


  18 in total

Review 1.  The Oswestry Disability Index.

Authors:  J C Fairbank; P B Pynsent
Journal:  Spine (Phila Pa 1976)       Date:  2000-11-15       Impact factor: 3.468

Review 2.  Lumbar interbody fusion: techniques, indications and comparison of interbody fusion options including PLIF, TLIF, MI-TLIF, OLIF/ATP, LLIF and ALIF.

Authors:  Ralph J Mobbs; Kevin Phan; Greg Malham; Kevin Seex; Prashanth J Rao
Journal:  J Spine Surg       Date:  2015-12

Review 3.  Comparison Between Posterior Lumbar Interbody Fusion and Transforaminal Lumbar Interbody Fusion for the Treatment of Lumbar Degenerative Diseases: A Systematic Review and Meta-Analysis.

Authors:  Tao Lan; Shi-Yu Hu; Yuan-Tao Zhang; Yu-Chen Zheng; Rui Zhang; Zhe Shen; Xin-Jian Yang
Journal:  World Neurosurg       Date:  2018-01-31       Impact factor: 2.104

Review 4.  Ropivacaine. A review of its pharmacology and therapeutic use in regional anaesthesia.

Authors:  A Markham; D Faulds
Journal:  Drugs       Date:  1996-09       Impact factor: 9.546

5.  Comparison of Effects of Hemostatic Gelatin Sponge Impregnated with Ropivacaine versus Normal Saline Applied on the Transverse Process of the Operated Vertebrae on Postoperative Pain in Patients Undergoing Spinal Instrumentation Surgery: A Randomized Clinical Trial.

Authors:  Maroun B Ghabach; Nakhle E Mhanna; Morad R Abou Al Ezz; Georges N Mezher; Monique J Chammas; Marc M Ghabach
Journal:  World Neurosurg       Date:  2019-05-20       Impact factor: 2.104

6.  A meta-analysis comparing ALIF, PLIF, TLIF and LLIF.

Authors:  Ian Teng; Julian Han; Kevin Phan; Ralph Mobbs
Journal:  J Clin Neurosci       Date:  2017-07-01       Impact factor: 1.961

7.  Postoperative extradural analgesia with morphine and ropivacaine. A double-blind comparison between placebo and ropivacaine 10 mg/h or 16 mg/h.

Authors:  K Axelsson; E Johanzon; P Essving; J Weckström; G Ekbäck
Journal:  Acta Anaesthesiol Scand       Date:  2005-09       Impact factor: 2.105

Review 8.  Minimally invasive versus open transforaminal lumbar interbody fusion for treatment of degenerative lumbar disease: systematic review and meta-analysis.

Authors:  Kevin Phan; Prashanth J Rao; Andrew C Kam; Ralph J Mobbs
Journal:  Eur Spine J       Date:  2015-03-27       Impact factor: 3.134

9.  Guidelines for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 8: lumbar fusion for disc herniation and radiculopathy.

Authors:  Daniel K Resnick; Tanvir F Choudhri; Andrew T Dailey; Michael W Groff; Larry Khoo; Paul G Matz; Praveen Mummaneni; William C Watters; Jeffrey Wang; Beverly C Walters; Mark N Hadley
Journal:  J Neurosurg Spine       Date:  2005-06

10.  Application of Gelatin Sponge Impregnated with a Mixture of 3 Drugs to Intraoperative Nerve Root Block to Promote Early Postoperative Recovery of Lumbar Disc Herniation.

Authors:  Jin Peng Du; Yong Fan; Ding Jun Hao; Yun Fei Huang; Jia Nan Zhang; Lei Hong Yuan
Journal:  World Neurosurg       Date:  2018-03-31       Impact factor: 2.104

View more
  2 in total

1.  Precise puncture combined with simplified percutaneous vertebroplasty to treat osteoporotic vertebral compression fractures: a comparative analysis with conventional percutaneous vertebroplasty.

Authors:  Jutao Pang; Bin Liu; Hong Chen; Wei Zhang; Jianhua Sun; Xinhu Zhang
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

2.  Clinical and radiological comparison of the zero-profile anchored cage and traditional cage-plate fixation in single-level anterior cervical discectomy and fusion.

Authors:  Jun Zhang; Shanxi Wang; Xiangyu Tang; Wei Xiong; Hua Wu; Chaoxu Liu; Feng Li
Journal:  Eur J Med Res       Date:  2022-09-30       Impact factor: 4.981

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.